Trump II, Year One: Updated Version Seems Buggy For Pharma

 
• By Nielsen Hobbs
  
Pharma firms are working on the best prescription for navigating the second Trump administration (Illustation by Nielsen Hobbs; Citeline/Images from Shutterstock)

More from Manufacturing Focus

More from In Vivo